Company Filing History:
Years Active: 2022
Title: The Innovations of Aiwu Zhou
Introduction
Aiwu Zhou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical biology, particularly in the development of PD-L1 binding polypeptides. His work has the potential to impact cancer treatment and immunotherapy.
Latest Patents
Aiwu Zhou holds 1 patent related to his research. His patent focuses on a PD-L1 binding polypeptide or composite. The invention discloses a high-resolution crystal structure of a complex formed by the PD-L1-blocking heavy-chain single-domain antibody KN035 binding with PD-L1. This groundbreaking work also includes the development of novel PD-L1 binding polypeptides or compounds based on the crystal structure and their various uses.
Career Highlights
Aiwu Zhou is associated with Suzhou Alphamab Co., Ltd., where he continues to advance his research in medical biology. His expertise in the field has positioned him as a key figure in the development of innovative therapeutic solutions.
Collaborations
He has collaborated with notable colleagues, including Ting Xu and Yuhao Jin, who share his commitment to advancing medical research and innovation.
Conclusion
Aiwu Zhou's contributions to the field of medical biology through his patent and work at Suzhou Alphamab Co., Ltd. highlight his role as an influential inventor. His research on PD-L1 binding polypeptides is paving the way for new therapeutic approaches in cancer treatment.